Becton, Dickinson and Company (BDX), or BD, operated under three business segments until 2014. It then underwent organizational restructuring, effective October 1, 2015, to better align its business model to the strategic vision and goals of the company. Consequently, the company operates under two business segments: BD Medical and BD Life Sciences.